Epidemiology of Multidrug-Resistant Microorganisms among Nursing Home Residents in Belgium

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Jans, Béatrice ^a   Schoevaerdts, Didier ^b,c   Huang, Te Din ^c   Berhin, Catherine ^c   Latour, Katrien ^a   Bogaerts, Pierre ^c   Nonhoff, Claire ^d   Denis, Olivier ^d   Catry, Boudewijn ^a   Glupczynski, Youri ^c  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTACID AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; LEVOFLOXACIN; LINCOMYCIN; PENICILLINASE;

AGED; ARTICLE; BACTERIAL COLONIZATION; BELGIUM; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECUBITUS; DISABILITY; DISEASE CARRIER; DRUG EXPOSURE; ENRICHMENT CULTURE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NURSING HOME; NURSING HOME PATIENT; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SKIN DEFECT; SOCIAL CLASS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BELGIUM; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; QUESTIONNAIRES; RISK FACTORS;

ENTEROBACTERIACEAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84878499727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064908     Document Type: Article

References (42)

1. Cohen ML, (2000) Changing patterns of infectious disease. Nature 406: 762-767.
2. Zirakzadeh A, Gastineau DA, Mandrekar JN, Burke JP, Johnston PB, et al. (2008) Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 41: 385-392.
3. Safdar N, Bradley EA, (2008) The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 121: 310-315.
4. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, et al. (2007) Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 45: 846-852.
5. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, et al. (2006) Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50: 1257-1262.
6. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO, (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32: 1162-1171.
7. Denis O, Jans B, Deplano A, Nonhoff C, De Ryck R, et al. (2009) Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. J Antimicrob Chemother 64: 1299-1306.
8. Benenson S, Cohen MJ, Block C, Stern S, Weiss Y, et al. (2009) Vancomycin-resistant enterococci in long-term care facilities. Infect Control Hosp Epidemiol 30: 786-789.
9. Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, et al. (2009) Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 64: 635-641.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
11. Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility tests: Eigteenth informal supplement M100-S18. CLSI, Wayne PA, USA.
12. Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, et al. (2005) Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 56: 1103-1106.
13. Dutka-Malen S, Evers S, Courvalin P, (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33: 1434.
14. March A, Aschbacher R, Dhanji H, Livermore DM, Bottcher A, et al. (2010) Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect 16: 934-944.
15. Andersson H, Lindholm C, Iversen A, Giske CG, Ortqvist A, et al. (2012) Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: Healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis 44: 641-649.
16. Bertrand X, Amara M, Sauget M, Clement MC, Talon D, et al. (2012) Extended-spectrum beta-lactamase-producing Enterobacteriacae: unexpected low prevalence of carriage in elderly French residents. Age Ageing 41: 233-237.
17. Trick WE, Weinstein RA, DeMarais PL, Kuehnert MJ, Tomaska W, et al. (2001) Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 49: 270-276.
18. Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D'Agata EM, (2008) Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 56: 1276-1280.
19. Bula CJ, Ghilardi G, Wietlisbach V, Petignat C, Francioli P, (2004) Infections and functional impairment in nursing home residents: a reciprocal relationship. J Am Geriatr Soc 52: 700-706.
20. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, et al. (2004) Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292: 1955-1960.
21. Neal KR, Scott HM, Slack RC, Logan RF, (1996) Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ 312: 414-415.
22. Agastya G, West BC, Callahan JM, (2000) Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol 22: 357-372.
23. Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, et al. (2002) Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 30: 1118-1122.
24. Zekry D, Loures Valle BH, Graf C, Michel JP, Gold G, et al. (2012) Prospective comparison of 6 comorbidity indices as predictors of 1-year post-hospital discharge institutionalization, readmission, and mortality in elderly individuals. J Am Med Dir Assoc 13: 272-278.
25. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, et al. (2005) Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 24: 17-22.
26. Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, et al. (2007) How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 35: 97-101.
27. Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, et al. (2011) Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 17: 1201-1208.
28. Jans B, Glupczynski Y, Denis O (2013) Surveillance des bactéries résistantes aux antibiotiques dans les hôpitaux belges. ISP-WIV: Rapport annuel 2011 IPH/EPI Reports Nr 2012-024: D/2012/2505/2050. Available: http://www.nsih.be/download/MRSA/MRSA_ESBL_CPE_Y2011/RAPPORT_COMPLET_Y2011_FRV2012.pdf. Accessed 2013 March 05.
29. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, et al. (2011) Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother 66: 37-47.
30. Costers M, Viseur N, Catry B, Simon A, (2012) Four multifaceted countrywide campaigns to promote hand hygiene in Belgian hospitals between 2005 and 2011: impact on compliance to hand hygiene. Euro Surveill 17.
31. Belgian Infection Control Society (2008) Détection, surveillance, prévention et contrôle de la transmission d'entérobactéries productrices de BLSE: recommandations et réponse à 60 questions pratiques. BICS website pp. 1-35 Available: http://www.belgianinfectioncontrolsociety.be/index.php?page=esbl&hl=fr_FR. Accessed 2013 Feb 05.
32. GDEPIH-GOSPIZ (2003) Recommendations pour le contrôle et la prévention de la transmission de Staphylococcus Aureus Résistant à la Méthicilline dans les hôpitaux belges. Conseil Supérieur d'Hygiène-BICS Website pp. 1-28 Available: http://www.belgianinfectioncontrolsociety.be/index.php?page=mrsa&hl=fr_FR. Accessed 2013 March 05.
33. GDEPIH-GOSPIZ (2005) Mesures préventives de la transmission de Staphylococcus Aureus résistant à la Méthicilline (MRSA) dans les maisons de repos et de soins (MRS). BICS website pp. 1-23 Available: http://www.belgianinfectioncontrolsociety.be/index.php?page=mrsa&hl=fr_FR. Accessed 2013 March 05.
34. Van Gastel E, Costers M, Peetermans WE, Struelens MJ, (2010) Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother 65: 576-580.
35. Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, et al. (2011) Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill 16.
36. Lautenbach E, Harris AD, Perencevich EN, Nachamkin I, Tolomeo P, et al. (2005) Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother 49: 798-800.
37. Lautenbach E, Bilker WB, Tolomeo P, Maslow JN, (2008) Impact of diversity of colonizing strains on strategies for sampling Escherichia coli from fecal specimens. J Clin Microbiol 46: 3094-3096.
38. Lautenbach E, Tolomeo P, Mao X, Fishman NO, Metlay JP, et al. (2006) Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital. Antimicrob Agents Chemother 50: 3939-3943.
39. Pacio GA, Visintainer P, Maguire G, Wormser GP, Raffalli J, et al. (2003) Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol 24: 246-250.
40. Glupczynski Y, Huang TD, Bouchahrouf W, Rezende de Castro R, Bauraing C, et al. (2012) Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents 39: 168-172.
41. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, et al. (2012) Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 18: 432-438.
42. Chevalier P, De Sutter A (2008) Guide belge des traitements anti-infectieux en pratique ambulatoire. Belgian Antibiotic Policy Coordination Committee; Service Public Fédéral Santé Publique, Sécurité de la chaîne alimentaire et Environnement 2° éd. Bruxelles: Available: http://www.cbip.be/files/832250_BW_FR_832201_832284_IC.pdf. Accessed 2013 March 05.